Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Rue Michel Servet 1211, Geneva, Switzerland; Section of Pharmaceutical Sciences, University of Geneva, 1 Rue Michel Servet 1211, Geneva, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Rue Michel Servet 1211, Geneva, Switzerland; Section of Pharmaceutical Sciences, University of Geneva, 1 Rue Michel Servet 1211, Geneva, Switzerland.
Int J Pharm. 2024 Apr 10;654:123987. doi: 10.1016/j.ijpharm.2024.123987. Epub 2024 Mar 11.
It is well known that protein corona affects the "biological identity" of nanoparticles (NPs), which has been seen as both a challenge and an opportunity. Approaches have moved from avoiding protein adsorption to trying to direct it, taking advantage of the formation of a protein corona to favorably modify the pharmacokinetic parameters of NPs. Although promising, the results obtained with engineered NPs still need to be completely understood. While much effort has been put into understanding how the surface of nanomaterials affects protein absorption, less is known about how proteins can affect corona formation due to their specific physicochemical properties. This review addresses this knowledge gap, examining key protein factors influencing corona formation, highlighting current challenges in studying protein-protein interactions, and discussing future perspectives in the field.
众所周知,蛋白质冠层会影响纳米粒子(NPs)的“生物学特性”,这既被视为挑战,也被视为机遇。研究方法已从避免蛋白质吸附转变为试图引导其吸附,利用蛋白质冠层的形成来有利地改变 NPs 的药代动力学参数。尽管很有前景,但仍需要完全理解用工程纳米粒子获得的结果。虽然已经投入大量精力来了解纳米材料的表面如何影响蛋白质的吸收,但由于蛋白质的特殊物理化学性质,对于蛋白质如何影响冠层形成的了解较少。本综述针对这一知识空白,探讨了影响冠层形成的关键蛋白质因素,强调了当前研究蛋白质-蛋白质相互作用所面临的挑战,并讨论了该领域的未来展望。